Name: Advances in Enzyme Regulation: Volume 41 (en Inglés)
Price: 7950.70 MXN
Availability: InStock
Author: Weber, George
ISBN: 9780080439549

Envío gratis

portada Advances in Enzyme Regulation: Volume 41 (en Inglés)

Formato

Libro Físico

Editorial

Pergamon

Autor

Weber, George

Idioma

Inglés

N° páginas

580

Encuadernación

Tapa Dura

Dimensiones

14.5 x 22.5 x 2.5 cm

ISBN13

9780080439549

Categorías

Ciencias básicas de la medicina preclínica
Bioquímica

Advances in Enzyme Regulation: Volume 41 (en Inglés)

Weber, George (Autor) · Pergamon · Tapa Dura

Libro Nuevo

$ 7,950.70

$ 15,901.40

Ahorras: $ 7,950.70

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 04 de Junio y el Viernes 14 de Junio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Advances in Enzyme Regulation: Volume 41 (en Inglés)"

Stepping ahead of the general front, Volume 41 in the series Advances in Enzyme Regulation moves the studies of mammalian enzymic and metabolic regulation forward.This volume was dedicated on the centenary of his birth to Sir Hans A. Krebs who gave the Special Symposium lectures for 15 years. George Weber spoke on the joint work he carried out in Oxford with Krebs and his associates, entitled "Cancer and Clinical Targeting."Much of the Symposium centered on novel aspects of signal transduction, including Inositol Signaling and on phosphatidylinositol 3'kinase and kinase B. The Special Symposium Lecture was given on Inositol Lipid Signaling in the Nucleus.The location and regulation of protein kinases were discussed.Clinical aspects of enzyme regulation were presented featuring studies on dihydrophyrimidine dehydrogenase, development, citrullinemia and human melanoma heparanase.Drug targeting and resistance were reviewed featuring etoposide and tumor vasculature. Regulation of pyruvate dehydrogenase kinase and abrogration of cytokine-dependency were analyzed. Challenging results on mRNA stability and apoptosis were presented covering cyclooxygenase-2 inhibitors, lysosomal cathepsins, human breast tumors and actin reorganization. The contents listed below provide a complete overview of topics and speakers.